Consumer Health

2023 saw rising demand for dermatologicals supported by the return to pre-pandemic daily routines and lifestyles as greater exposure to the causes of various mild skin conditions resulted in a higher incidence of skin infections and parasite-related…

Many consumers in South Africa rely on pharmacist recommendations when it comes to dermatological products. Most consumers within South Africa are highly unlikely to visit a doctor or even a dermatologist to treat some dermatological issues. As a…

Dermatologicals has seen a return to growth in current value terms in 2023, which is mainly due to the waning impact of COVID-19 on consumer lifestyles and behaviours. Antipruritics is one of the largest categories within dermatologicals and has also…

In the Philippines, one interesting aspect of OTC products in general and cough, cold and allergy (hay fever) remedies in particular is that consumers are generally very aware of the active ingredients that are contained within these products and the…

During the review period, the flu and allergy season in South Africa was rife specifically during the winter periods. Given the presence of several flu strains and allergies, consumers reached out to cough, cold and allergy (hay fever) products to…

Sales of cough, cold and allergy (hay fever) remedies in Japan have continued to recover in 2023. This is largely due to increased opportunities for consumers to go out and a shift away from the practice of wearing face masks on a daily basis. With…

Positive sales growth was registered across most categories of consumer health in the Philippines in 2023 as the strong focus on health and wellbeing that has spread among the population since the peak of the COVID-19 pandemic continued to spur…

During the review period, many consumers have been facing financial difficulties as the cost of living in South Africa has been increasing on a monthly basis. For many consumers, their health is an afterthought with most instead prioritising…

Sales of OTC products in Japan continue on the path to recovery in 2023 as the country sees an end to the pandemic. With the World Health Organisation (WHO) declaring the pandemic to be over in early 2023 there have been increased opportunities to go…

Towards the end of the review period, demand for analgesics was supported by the widening of the consumer base for these products as the advantages of using analgesics to manage headaches and other moderate types of pain became better known among the…